Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lemaitre Vascular (LMAT)

Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,905,624
  • Shares Outstanding, K 22,686
  • Annual Sales, $ 219,860 K
  • Annual Income, $ 44,040 K
  • EBIT $ 62 M
  • EBITDA $ 72 M
  • 60-Month Beta 0.68
  • Price/Sales 8.60
  • Price/Cash Flow 34.90
  • Price/Book 4.98

Options Overview Details

View History
  • Implied Volatility 39.91% (+0.68%)
  • Historical Volatility 25.53%
  • IV Percentile 69%
  • IV Rank 56.21%
  • IV High 53.92% on 04/21/25
  • IV Low 21.93% on 09/02/25
  • Expected Move (DTE 5) 4.29 (5.11%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 235
  • Open Int (30-Day) 253
  • Expected Range 79.71 to 88.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 4
  • High Estimate 0.67
  • Low Estimate 0.66
  • Prior Year 0.49
  • Growth Rate Est. (year over year) +36.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.60 +2.94%
on 12/02/25
92.25 -8.94%
on 11/13/25
-5.97 (-6.64%)
since 11/12/25
3-Month
81.57 +2.98%
on 11/07/25
93.93 -10.57%
on 09/17/25
-8.29 (-8.98%)
since 09/12/25
52-Week
71.42 +17.61%
on 04/07/25
105.55 -20.42%
on 02/26/25
-16.28 (-16.23%)
since 12/12/24

Most Recent Stories

More News
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Question

1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Question

PATH : 17.42 (-3.38%)
FSLR : 254.80 (-6.61%)
LMAT : 84.00 (+0.77%)
1 Reason LMAT is Risky and 1 Stock to Buy Instead

1 Reason LMAT is Risky and 1 Stock to Buy Instead

LMAT : 84.00 (+0.77%)
3 Healthcare Stocks We Steer Clear Of

3 Healthcare Stocks We Steer Clear Of

TECH : 58.51 (-2.90%)
LMAT : 84.00 (+0.77%)
CNMD : 40.83 (+2.46%)
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

CORT : 87.99 (+0.99%)
ELAN : 21.29 (+0.09%)
LMAT : 84.00 (+0.77%)
PEN : 312.02 (+0.20%)
RMD : 252.27 (-0.05%)
3 Russell 2000 Stocks Walking a Fine Line

3 Russell 2000 Stocks Walking a Fine Line

LMAT : 84.00 (+0.77%)
SUPN : 47.16 (+1.40%)
WNC : 9.75 (-2.40%)
5 Must-Read Analyst Questions From LeMaitre’s Q3 Earnings Call

5 Must-Read Analyst Questions From LeMaitre’s Q3 Earnings Call

LMAT : 84.00 (+0.77%)
LeMaitre to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London...

LMAT : 84.00 (+0.77%)
LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook

LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook

LMAT : 84.00 (+0.77%)
LeMaitre: Q3 Earnings Snapshot

LeMaitre: Q3 Earnings Snapshot

LMAT : 84.00 (+0.77%)
LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 Earnings

LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 Earnings

LMAT : 84.00 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and...

See More

Key Turning Points

3rd Resistance Point 86.97
2nd Resistance Point 85.78
1st Resistance Point 84.89
Last Price 84.00
1st Support Level 82.81
2nd Support Level 81.63
3rd Support Level 80.74

See More

52-Week High 105.55
Fibonacci 61.8% 92.51
Fibonacci 50% 88.49
Fibonacci 38.2% 84.46
Last Price 84.00
52-Week Low 71.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar